La Jolla Pharmaceutical Co (LJPC) Financials

$6.22

$0.00 (0.00%)

As on 22-Aug-2022 09:30EDT

Market cap

$155 Mln

Revenue (TTM)

$46 Mln

P/E Ratio

47.8

P/B Ratio

0

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Operating Revenue	46.49	75.72	33.42	23.05	10.06	--
Cost of Revenue	8.86	13.49	7.82	2.39	1.64	84.58
Gross Profit	37.63	62.23	25.60	20.66	8.41	-84.58
Operating Expenses	41.89	40.40	61.44	130.46	202.46	115.43
Operating Profit (EBIT)	-2.57	21.83	-35.84	-109.80	-194.05	-115.43
Other Income	--	--	--	2.13	-5.42	0.62
Profit before Tax	4.02	19.71	-39.42	-116.51	-199.47	-114.80
Provision for Tax	0.05	0.05	--	--	--	--
Profit after Tax (Net Income)	3.97	19.66	-39.42	-116.51	-199.47	-114.80
Minority Interest	--	--	--	--	--	--
Consolidated Profit	3.97	19.66	-39.42	-116.51	-199.47	-114.80

Liabilities ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Shareholder's Funds	-69.47	-66.74	-88.09	-55.99	35.92	88.20
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	152.34	150.33	147.99	163.65	137.93	12.79
Current Liabilities	16.49	17.64	12.34	24.59	30.44	18.55
Total Liabilities	115.86	101.23	72.24	132.25	204.29	119.54

Assets ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Non-Current Assets	33.01	33.92	35.79	34.79	23.18	25.48
Current Assets	66.36	67.32	36.46	97.46	181.12	94.06
Total Assets	115.86	101.23	72.24	132.25	204.29	119.54
Total Debt*	0.23	2.64	0.54	29.25	--	--
Net Current Assets	49.87	49.68	24.12	72.87	150.68	75.51

Cashflow ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Cash From Operating Activities	--	28.24	-37.64	-84.95	-152.37	-84.88
Cash Flow from Investing Activities	--	-0.01	-30.95	-0.70	-2.34	-9.19
Cash from Financing Activities	--	-2.79	1.12	0.86	236.40	119.26
Net Cash Inflow / Outflow	--	25.45	-67.47	-84.78	81.69	25.19

Financials Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Adjusted EPS ($)	0.10	0.58	-1.46	-4.32	-7.98	-5.47
Cash EPS ($)	--	0.63	-1.31	-4.15	-7.80	-5.41
Adjusted Book Value ($)	--	--	--	--	1.44	4.20
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	0.83	-1.39	-3.15	-6.09	-4.04
Free Cash Flow per Share ($)	--	0.83	-1.39	-3.17	-6.19	-4.48

Profitability Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
ROCE (%)	--	-25.93	68.98	-2,538.85	-321.41	-153.85
ROE (%)	--	-25.40	54.72	1,161.07	-321.41	-153.85
ROA (%)	3.42	22.67	-38.56	-69.24	-123.19	-120.63
EBIT Margin (%)	30.05	39.84	-87.88	-458.64	-1,910.96	--
Net Margin (%)	8.54	25.96	-117.96	-462.66	-4,300.75	-18,397.92
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Revenue Growth (%)	-33.79	1.27	0.45	1.29	--	-1.00
EBIT Growth (%)	4.35	202.71	72.22	44.98	-66.48	-47.63
Net Profit Growth (%)	36.25	149.87	66.16	41.59	-73.75	-46.84
EPS Growth (%)	440.86	1.40	0.66	0.46	-0.46	-0.19
Book Value Growth (%)	-9.44	--	--	--	--	--

Valuation Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Price / Earnings	47.85	8.04	-2.66	-0.91	-1.18	-5.89
Price / Book Value	--	-2.37	-1.19	-1.90	6.56	7.66
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	6.99	3.56	-3.32	-0.47	-0.34	-5.12
Close Price ($)	3.19	4.65	3.88	3.93	9.43	32.18
High Price ($)	5.08	7.85	9.38	13.90	41.36	39.28
Low Price ($)	3.10	3.35	3.36	2.30	9.08	16.71
Market Cap ($ Cr)	155.11	--	--	--	--	--

Solvency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debt to Equity	--	-0.04	-0.01	-0.52	--	--
Short term debt to equity ratio	0.00	-0.04	0.00	-0.05	--	--
Current Ratio	4.02	3.82	2.95	3.96	5.95	5.07
Quick Ratio	3.52	3.46	2.47	3.87	5.88	5.07
Interest Coverage	1.40	2.88	-2.92	-9.81	-26.31	--

Operating Efficiency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debtors to sales (%)	12.75	15.83	17.46	12.84	13.73	--
Asset Turnover	0.40	0.87	0.33	0.14	0.06	--
Receivable days	--	42.98	48.06	34.39	50.16	--
Inventory Days	--	166.45	192.08	323.03	224.53	--
Payable days	--	68.24	162.07	973.36	2,229.29	39.16
Cash Conversion Cycle	--	141.19	78.07	-615.95	-1,954.60	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.